Clinical Significance
- Identifies eligibility for targeted therapies like Alpelisib.
- Provides precise genomic profiling of the tumor.
- Assists in personalizing treatment to improve survival rates.
PIK3CA Mutation Test Price | Lahalak Medical Platform
This advanced molecular assay detects PIK3CA gene mutations in metastatic breast cancer patients, identifying candidates for targeted therapy to enhance treatment outcomes and provide personalized medical care strategies.
Scientific name: PIK3CA Gene Mutation Testing for Breast Cancer
A sophisticated molecular laboratory test designed to detect PIK3CA gene mutations in HR+/HER2- metastatic breast cancer patients, enabling precise selection of targeted therapies for better clinical results.
Service type
Molecular Laboratory Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Sample collection or tissue intake
- Advanced molecular analysis
- Detailed medical report
Medical Service Information
Target Groups
- Patients with advanced or metastatic breast cancer.
- Hormone receptor-positive (HR+) cases.
- HER2-negative (HER2-) cases.
Understanding Results
- Positive Result: Indicates mutation presence, making targeted therapy a viable option.
- Negative Result: No mutation detected; alternative treatment protocols will be considered.
Conditions & Notices
- Preferably provide original biopsy report if available
- Consult with your oncologist before testing
Medical services you might also like
